Insights into the prevalence and resistance patterns of candida species among diabetic patients in Cameroon: Potential paths for alternative treatments

Simple item page
dc.contributor.authorAbrantes, Pedro
dc.contributor.authorTsague, Kenfack
dc.contributor.authorDongmo, Dongho
dc.contributor.authorKouipou, Toghueo
dc.date.accessioned2024-11-25T13:11:46Z
dc.date.available2024-11-25T13:11:46Z
dc.date.issued2024
dc.description.abstractThe study aimed to fill the knowledge gap regarding the prevalence of Candida infections in diabetic patients and their sensitivity to antifungal drugs. Clinical samples from diabetic patients were collected at Yaoundé Central Hospital and Candida species identified. The ability of these species to form biofilms was assessed, and their susceptibility to usual antifungal drugs, as well as some plant extracts and fractions, was determined. Mycological diagnosis was performed on the collected samples. The Candida species isolated and identified were subjected to the crystal violet assay in a microtiter plate to examine their biofilm-forming abilities. The disk diffusion method was used for susceptibility testing for reference antifungals, while the broth dilution method was employed for plant extracts and fractions. These were obtained from the leaves of Picralima nitida, Phragmanthera capitata, and Spondia cythereae, and the roots and fruits of Garcinia Kola. The study found that 43.18% of the 396 collected samples were colonized by various Candida species, including Candida albicans, Candida tropicalis, Candida parapsilosis, Candida glabrata, Candida krusei, Candida guillermondii, Candida lusitaniae, and Candida ciferrii. Biofilm production was observed in 46.04% of the isolates, with non-albicans Candida species showing a higher rate than Candida albicans. The isolates exhibited high resistance to nystatin and ketoconazole, dose-dependent sensitivity to miconazole, and sensitivity to econazole and fluconazole. Multidrug resistance was observed in 24.75% of the isolates. While none of the crude extracts showed activity against the tested Candida, six out of 25 fractions (PnlB, PclA, PclW, SclA, SclW, and GkfW) displayed fungistatic activities on some strains. These findings offer valuable insights into the prevalence and antifungal resistance patterns of Candida species in diabetic patients in Cameroon. They also suggest the potential for alternative treatments using plant fractions.
dc.identifier.citationTsague, I.K., Ngouana, T.K., Dongmo, F.D., Kouipou, R.T., Dougue, A., Yimgang, L., Abrantes, P.M.D.S., Sameza, M.L., Boyom, F.F. and Choudhary, M.I., 2024. Insights into the Prevalence and Resistance Patterns of Candida Species among Diabetic Patients in Cameroon: Potential Paths for Alternative Treatments. American Journal of Microbiological Research, 12(2), pp.18-26.
dc.identifier.urihttps://doi.org/10.12691/ajmr-12-2-2
dc.identifier.urihttps://hdl.handle.net/10566/19725
dc.language.isoen
dc.publisherScience and Education Publishing
dc.subjectdiabetes
dc.subjectCandida
dc.subjectbiofilms
dc.subjectantifungal susceptibility
dc.subjectantifungal drugs
dc.titleInsights into the prevalence and resistance patterns of candida species among diabetic patients in Cameroon: Potential paths for alternative treatments
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
abrantes_insights into the prevalence_2024.pdf
Size:
297.71 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (Medical Bioscience)